---
title: "COOPER COMPANIES, INC. 2Q 2026: Revenue $1.08B, Net income ($77.9M), EPS ($0.4) — 10-Q Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288904887.md"
description: "Cooper Companies reported Q2 2026 revenue of $1.08B, up 7.9% YoY, driven by CooperVision and CooperSurgical. However, the company posted a net loss of ($77.9M) and diluted EPS of ($0.4), compared to prior year profits. The loss was significantly impacted by a $271.6M litigation accrual at CooperSurgical. Despite the net loss, operating cash flow improved, supporting capital spending and share repurchases."
datetime: "2026-06-05T20:51:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288904887.md)
  - [en](https://longbridge.com/en/news/288904887.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288904887.md)
---

# COOPER COMPANIES, INC. 2Q 2026: Revenue $1.08B, Net income ($77.9M), EPS ($0.4) — 10-Q Summary

Cooper Companies, Inc. reported second-quarter 2026 results with consolidated revenue of $1.08B, up 7.9% from $1B a year earlier, while the company recorded a net loss of ($77.9M) versus net income of $87.7M in the prior-year quarter; diluted EPS was ($0.4) compared with $0.44 a year ago.

**Financial Highlights**

Metric

Current quarter

Prior year quarter

YoY change

Revenue¹

$1.08B

$1B

7.9%

Net income²

($77.9M)

$87.7M

(188.8%)

Diluted EPS³

($0.4)

$0.44

(190.9%)

_¹ Reported as “Net sales”. ² Reported as “Net income (loss)”. ³ Reported as “Earnings (loss) per share”._

**Business Highlights**

-   Revenue growth of about 8% was driven by CooperVision (strong spherical and toric contact lens demand) and CooperSurgical (fertility services).
-   Geographic strength in the Americas and EMEA offset softness in Asia Pacific, notably Japan, which weighed on regional mix.
-   Brand momentum from Biofinity, MyDay and MiSight— including FDA‑approved MiSight 1 day—supported contact lens and myopia-management adoption.
-   CooperSurgical recorded a $271.6M net litigation accrual during the quarter, materially affecting operating results and defense costs.
-   Operating cash flow improved, supporting higher capital spending and continued share repurchases while funding operational needs.

Original SEC Filing: COOPER COMPANIES, INC. \[ COO \] - 10-Q - Jun. 05, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [COO.US](https://longbridge.com/en/quote/COO.US.md)

## Related News & Research

- [Cooper Companies Posts Q2 Loss Hurt By One-Time Litigation Charge, Revenue Rises 8%](https://longbridge.com/en/news/288776393.md)
- [Cooper Companies Q2 revenue, profit beat estimates on product launches, strong demand](https://longbridge.com/en/news/288769821.md)
- [Dear Future ERock Stock Fans, Mark Your Calendars for June 10](https://longbridge.com/en/news/288962191.md)
- [18:00 ETHuntington Announces Creation of the Boswell Chair of Surgery, Names Gabriel Akopian, MD, as Inaugural Chair](https://longbridge.com/en/news/289107218.md)
- [Dear Oracle Stock Fans, Mark Your Calendars for June 10](https://longbridge.com/en/news/289074626.md)